SCHEMBL29352652

SCHEMBL29352652

Cc1nc(Oc2ccc(-c3cncs3)cc2)ccc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 1/20 0.36
▸ F2 P00734 1/20 0.35
▸ F10 P00742 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ PRSS2 P07478 1/20 0.35
▸ PRSS3 P35030 1/20 0.35
▸ ST14 Q9Y5Y6 1/20 0.35
▸ MAP4K4 O95819 3/20 0.34
▸ RAB9A P51151 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ LTA4H P09960 2/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ CHEK2 O96017 1/20 0.32
▸ DHFR P00374 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529908 1.00 CD38 (0.36) CD38F2F10PRSS1PRSS2
SCHEMBL28697675 0.84 CD38 (0.38) CD38RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL22529968 0.82 TTK (0.32) CD38MEN1KMT2ADYRK1ACARM1
SCHEMBL22530730 0.79 MERTK (0.36) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL29349936 0.79 MERTK (0.36) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL22529949 0.77 CD38 (0.38) CD38RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL29354030 0.77 CD38 (0.38) CD38RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL22547106 0.77 TSHR (0.47) F2F10PRSS1PRSS2PRSS3
SCHEMBL29350209 0.77 TSHR (0.47) F2F10PRSS1PRSS2PRSS3
SCHEMBL28693342 0.76 CHEK1 (0.40) CD38F2PRSS1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994001-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-11-22 — — CN disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 — — CN disclosed
EP-3953335-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS Cellestia Biotech AG (CH) 2022-02-16 — — EP disclosed
CN-113966324-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2022-01-21 — — CN disclosed
Send feedback